Business Trends– category –
-
Future of RNA Manufacturing: AI and Continuous Processing to Boost IVT Efficiency, Reduce Production Costs, and Facilitate Distributed Production
(Industry analysis/expert opinion) International Overview The future of RNA manufacturing is set to be optimized by integrating artificial intelligence (AI) and machine learning with continuous processes across all stages, from IVT effic... -
Cell and Gene Therapy Manufacturing Advances: Continuous Processing and Automated Bioreactors Tackle Scalability and Cost Challenges
News-Medical.net UK Overview Cell and gene therapy (CGT) manufacturing faces significant challenges in scalability, efficiency, and cost reduction, but new advancements in continuous processing and closed, automated bioreactor technologi... -
FUJIFILM Biotechnologies Drives $7 Billion Expansion in US and Europe, Quadrupling iPSC Production Capacity and Automating with AI
Drug Discovery and Development USA Overview FUJIFILM Biotechnologies is leading a $7 billion expansion across the US and Europe, with FUJIFILM Cellular Dynamics opening a new iPSC manufacturing headquarters to quadruple cell production c... -
PAK BioSolutions’ GMP Purification System Supports First-in-Human Trial Filing, Achieves 4x Faster Production Than Existing Facilities
FirstWord Pharma International Overview A major biopharmaceutical company has filed its first-in-human (FIH) trial, supported by PAK BioSolutions' GMP purification system. This PAK system utilizes a continuous manufacturing approach, cap... -
NTHRYS Achieves 40% Cost Reduction in Dual Antigen CAR-T Manufacturing, Offers Off-the-Shelf NK Cell Expansion Services
NTHRYS International Overview NTHRYS has successfully reduced manufacturing costs for dual antigen CAR-T cell scale-up by 40% while accelerating time-to-clinic. Furthermore, the company now offers clinical-grade NK cell expansion and cry... -
KELI Therapeutics Launches Integrated GMP Manufacturing Platform for Orthopedics, Nephrology, and Immunology, Cutting Development Costs and Accelerating Approvals
KELI Therapeutics Europe Overview KELI Therapeutics has successfully deployed a unified GMP manufacturing platform supporting five active cell therapy programs across orthopedics, nephrology, and immunology. This strategic consolidation ... -
Lonza’s OptiALTO™ Platform Achieves High Cell Density Culture, Significantly Reducing Biologics Manufacturing Costs
Lonza Switzerland Overview Lonza's OptiALTO™ platform enhances biologics manufacturing by enabling higher cell densities, which significantly reduces cost of goods by increasing productivity and efficient asset utilization. The platform ... -
Porton Advanced Fortifies End-to-End ATMP CDMO Services with Over 250 Global Clients
Porton Advanced China Overview Porton Advanced is strengthening its end-to-end CDMO solutions for Advanced Therapy Medicinal Products (ATMPs), serving over 250 global customers. The company offers cell engineering CMC services for autolo... -
GEA Invests €4M in German Biotech Pilot Centre to Accelerate Precision Fermentation & Cell Cultivation Scale-Up
FoodBev.com Germany Overview GEA has invested €4 million in a new Application and Technology Center (ATC) in Sarstedt, Germany, to accelerate the scale-up of precision fermentation and cell cultivation processes. The center provides pilo... -
Cell Therapy’s High Cost Rooted in Culture Flask Cytokine Strategy, Driving Shift to Quality over Quantity
Cell & Gene Therapy Review Global Overview A significant portion of cell therapy's cost problem originates in the culture flask, emphasizing the profound impact of cytokine strategy on cell quality and manufacturing economics. The focus ...
